InspireMD, Inc.
(NYSE Amex Equities : NSPR)

( )
NSPR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-1.70%97.220.6%$493.08m
ABTAbbott Laboratories
-1.54%82.940.8%$420.87m
ISRGIntuitive Surgical, Inc.
-1.31%513.722.4%$389.75m
TMOThermo Fisher Scientific Inc.
-0.44%292.231.0%$381.21m
BSXBoston Scientific Corporation
-0.79%41.391.1%$315.73m
BDXBecton, Dickinson and Company
-0.07%248.051.1%$314.30m
ALGNAlign Technology, Inc.
-2.88%268.086.3%$280.51m
EWEdwards Lifesciences Corporation
-2.55%187.061.2%$252.83m
SYKStryker Corporation
-0.70%202.371.3%$221.69m
DXCMDexCom, Inc.
-1.39%141.538.3%$195.92m
BAXBaxter International Inc.
-1.36%80.621.7%$185.36m
ABMDABIOMED, Inc.
-2.12%251.623.3%$147.60m
WATWaters Corporation
-0.09%211.083.8%$125.46m
ZBHZimmer Biomet Holdings, Inc.
-1.82%114.581.7%$122.92m
COOCooper Companies, Inc.
-0.49%328.372.2%$105.32m

Company Profile

InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.